Cart
sales@molnova.com
Quinfamide
CAS No. 62265-68-3
Quinfamide( WIN-40014 )
Catalog No. M26803 CAS No. 62265-68-3
Quinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 255 | In Stock |
|
| 50MG | 360 | In Stock |
|
| 100MG | 495 | In Stock |
|
| 200MG | 678 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuinfamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
In Vitro——
-
In Vivo——
-
SynonymsWIN-40014
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIF-2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62265-68-3
-
Formula Weight354.18
-
Molecular FormulaC16H13Cl2NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 125 mg/mL (352.93 mM)
-
SMILESClC(Cl)C(=O)N1CCCc2cc(OC(=O)c3ccco3)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu R, et al. 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. J Med Chem. 2019 Aug 8;62(15):6876-6893.
molnova catalog
related products
-
Ansamitocin p-3 B
Ansamitocin p-3 (Maytansinol isobutyrate) is an inhibitor of microtubule with IC50 of 3.4 μM for tubulin polymerization.
-
Laricitrin 3-O-gluco...
Laricitrin 3-O-glucoside is an antioxidant agent. Laricitrin 3-O-glucoside correlates significantly with DPPH assay and CUPRAC assay.
-
PRX-08066 Maleic aci...
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.
